Jeanne Tie, MD, MBChB

GI Oncology Now

<p>Professor Jeanne Tie of Peter MacCallum Cancer Centre discusses 5-year outcomes from the randomized DYNAMIC trial, which analyzed the use of ctDNA to guide adjuvant therapy in patients with stage 2 colon cancer.<br>
Dr. Tie discusses the beneficial results seen with a ctDNA-guided approach, and touches on its potential role in future clinical trials and real-world applications, along with which patients might benefit most from ctDNA-guided treatment strategies.</p>


Jessica Nye, PhD

Early Onset Colorectal Cancer: Trends, Epidemiology, and Screening

Colorectal Cancer

5-Year Outcomes of DYNAMIC: ctDNA-Guided Adjuvant Therapy in Colon Cancer

Bassel El-Rayes, MD

Breaking Silos, Building Impact: Dr. Bassel El-Rayes on Advancing Pancreatic and Neuroendocrine Cancer Research

Pancreatic Cancer

Latest News

Professor Jeanne Tie discusses 5-year outcomes from the DYNAMIC trial, which analyzed the use of ctDNA to guide adjuvant therapy in patients with colon cancer.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

GU Oncology Now

Lung Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Bile Duct

Colorectal

Esophageal

Gastric

GEP-NETs

GIST

Liver

Pancreatic

Conference Coverage

Video Insights

Roundtable